Stockholders’ Equity |
6 Months Ended | ||
|---|---|---|---|
Jun. 30, 2025 | |||
| Equity [Abstract] | |||
| Stockholders’ Equity |
Warrants
The Company had warrants to purchase approximately 462,963 shares of the Company’s common stock (the “Series A Warrants”) outstanding as of December 31, 2024. The Series A Warrants were immediately exercisable at a price of $33.00 per share of common stock. No Series A Warrants were exercised or forfeited during the three and six months ended June 30, 2025 and 2024. These warrants expired in February 2025 and, as a result, no Series A Warrants were outstanding as of June 30, 2025.
The Company also has warrants to purchase approximately 800 shares of the Company’s common stock outstanding as of both June 30, 2025 and December 31, 2024. These warrants have an exercise price of $29.09 per share of common stock and expire on July 3, 2026. None of these warrants were exercised or forfeited during the three and six months ended June 30, 2025 and 2024. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|